Intellia Therapeutics Announces Second Quarter 2019 Financial Results and Company Update

Go back to  Intellia Therapeutics Announces Second Quarter 2019 Financial Results and Company Update
(NASDAQ: NTLA) Delayed: 12.21 -0.53 (4.16%)
Previous Close $12.74    52 Week High $30.40 
Open $12.50    52 Week Low $11.86 
Day High $12.82    P/E N/A 
Day Low $12.19    EPS $0.00 
Volume 4,925,697